Fidelity Investments’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.98M Buy
26,223
+1,290
+5% +$147K ﹤0.01% 2348
2025
Q1
$2.62M Buy
24,933
+6,102
+32% +$642K ﹤0.01% 2358
2024
Q4
$2.02M Buy
18,831
+6,082
+48% +$652K ﹤0.01% 2444
2024
Q3
$1.28M Buy
12,749
+10,789
+550% +$1.08M ﹤0.01% 2532
2024
Q2
$165K Buy
1,960
+152
+8% +$12.8K ﹤0.01% 3095
2024
Q1
$132K Sell
1,808
-8,185
-82% -$598K ﹤0.01% 3175
2023
Q4
$714K Buy
9,993
+9,655
+2,857% +$690K ﹤0.01% 2568
2023
Q3
$20.3K Sell
338
-221
-40% -$13.2K ﹤0.01% 3794
2023
Q2
$40.3K Sell
559
-7
-1% -$505 ﹤0.01% 3539
2023
Q1
$41.6K Buy
566
+156
+38% +$11.5K ﹤0.01% 3528
2022
Q4
$27.4K Sell
410
-885
-68% -$59.1K ﹤0.01% 3659
2022
Q3
$70K Buy
1,295
+51
+4% +$2.76K ﹤0.01% 3363
2022
Q2
$69K Sell
1,244
-686
-36% -$38.1K ﹤0.01% 3449
2022
Q1
$135K Buy
1,930
+1,258
+187% +$88K ﹤0.01% 3356
2021
Q4
$64K Sell
672
-6
-0.9% -$571 ﹤0.01% 3178
2021
Q3
$59K Sell
678
-1,125
-62% -$97.9K ﹤0.01% 3176
2021
Q2
$148K Buy
1,803
+24
+1% +$1.97K ﹤0.01% 2975
2021
Q1
$169K Buy
1,779
+330
+23% +$31.3K ﹤0.01% 2846
2020
Q4
$90K Sell
1,449
-335
-19% -$20.8K ﹤0.01% 2896
2020
Q3
$107K Sell
1,784
-4,984
-74% -$299K ﹤0.01% 2781
2020
Q2
$472K Sell
6,768
-11,594
-63% -$809K ﹤0.01% 2514
2020
Q1
$832K Sell
18,362
-73,192
-80% -$3.32M ﹤0.01% 2358
2019
Q4
$5.96M Sell
91,554
-13,652
-13% -$888K ﹤0.01% 2007
2019
Q3
$6.53M Sell
105,206
-98,859
-48% -$6.14M ﹤0.01% 1968
2019
Q2
$14.5M Sell
204,065
-243,982
-54% -$17.4M ﹤0.01% 1750
2019
Q1
$35.1M Sell
448,047
-95,280
-18% -$7.47M ﹤0.01% 1367
2018
Q4
$46M Sell
543,327
-316,894
-37% -$26.8M 0.01% 1178
2018
Q3
$147M Buy
860,221
+153,965
+22% +$26.4M 0.02% 784
2018
Q2
$91.3M Buy
706,256
+22,469
+3% +$2.9M 0.01% 999
2018
Q1
$70.5M Sell
683,787
-5,317
-0.8% -$548K 0.01% 1138
2017
Q4
$58.9M Sell
689,104
-163,828
-19% -$14M 0.01% 1220
2017
Q3
$72.4M Buy
852,932
+209,788
+33% +$17.8M 0.01% 1125
2017
Q2
$48.7M Sell
643,144
-36,629
-5% -$2.77M 0.01% 1292
2017
Q1
$44.9M Sell
679,773
-99,386
-13% -$6.56M 0.01% 1359
2016
Q4
$49.4M Sell
779,159
-759,822
-49% -$48.2M 0.01% 1302
2016
Q3
$98M Sell
1,538,981
-152,926
-9% -$9.74M 0.01% 987
2016
Q2
$126M Buy
1,691,907
+128,560
+8% +$9.57M 0.02% 870
2016
Q1
$104M Sell
1,563,347
-216,885
-12% -$14.5M 0.01% 945
2015
Q4
$120M Buy
1,780,232
+113,333
+7% +$7.67M 0.02% 882
2015
Q3
$89.1M Buy
1,666,899
+33,070
+2% +$1.77M 0.01% 1001
2015
Q2
$103M Buy
1,633,829
+6,316
+0.4% +$398K 0.01% 1029
2015
Q1
$78.3M Buy
1,627,513
+105,195
+7% +$5.06M 0.01% 1141
2014
Q4
$50.5M Sell
1,522,318
-744,273
-33% -$24.7M 0.01% 1322
2014
Q3
$66.4M Sell
2,266,591
-488,142
-18% -$14.3M 0.01% 1170
2014
Q2
$107M Buy
2,754,733
+86,081
+3% +$3.34M 0.01% 963
2014
Q1
$112M Hold
2,668,652
0.02% 926
2013
Q4
$87.6M Hold
2,668,652
0.01% 1046
2013
Q3
$72.1M Buy
2,668,652
+711,251
+36% +$19.2M 0.01% 1103
2013
Q2
$45.7M Buy
+1,957,401
New +$45.7M 0.01% 1284